A case of advanced esophageal cancer responding remarkably to chemotherapy of TS-1 and weekly CDDP combined with radiotherapy

Yoshihisa Sakaguchi, Akira Kabashima, Hideki Yamamoto, Rinshun Shimabukuro, Yasutomo Ojima, Shinji Yamamura, Takashi Nishizaki, Hideya Tashiro, Toshimitsu Matsusaka

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A 66-year-old patient, who had advanced esophageal cancer with lymph node metastasis, was treated by neoadjuvant chemo-radiotherapy, followed by curative surgery. Chemotherapy of TS-1 (80 mg/m2) was administered orally for 21 days, and weekly intravenous administration of CDDP (20 mg/m2) was done 3 times. Radiotherapy at 2 Gy/day was combined 15 times (total 30 Gy). The tumor responded well to the treatment, and the size was remarkably reduced. Chemoradiotherapy using TS-1 and weekly CDDP revealed their efficacy for esophageal cancer.

Original languageEnglish
Pages (from-to)2159-2162
Number of pages4
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume31
Issue number13
Publication statusPublished - Jan 1 2004

Fingerprint

Esophageal Neoplasms
Radiotherapy
Drug Therapy
Chemoradiotherapy
Intravenous Administration
Lymph Nodes
Neoplasm Metastasis
Neoplasms
titanium silicide
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Sakaguchi, Y., Kabashima, A., Yamamoto, H., Shimabukuro, R., Ojima, Y., Yamamura, S., ... Matsusaka, T. (2004). A case of advanced esophageal cancer responding remarkably to chemotherapy of TS-1 and weekly CDDP combined with radiotherapy. Gan to kagaku ryoho. Cancer & chemotherapy, 31(13), 2159-2162.

A case of advanced esophageal cancer responding remarkably to chemotherapy of TS-1 and weekly CDDP combined with radiotherapy. / Sakaguchi, Yoshihisa; Kabashima, Akira; Yamamoto, Hideki; Shimabukuro, Rinshun; Ojima, Yasutomo; Yamamura, Shinji; Nishizaki, Takashi; Tashiro, Hideya; Matsusaka, Toshimitsu.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 31, No. 13, 01.01.2004, p. 2159-2162.

Research output: Contribution to journalArticle

Sakaguchi, Y, Kabashima, A, Yamamoto, H, Shimabukuro, R, Ojima, Y, Yamamura, S, Nishizaki, T, Tashiro, H & Matsusaka, T 2004, 'A case of advanced esophageal cancer responding remarkably to chemotherapy of TS-1 and weekly CDDP combined with radiotherapy', Gan to kagaku ryoho. Cancer & chemotherapy, vol. 31, no. 13, pp. 2159-2162.
Sakaguchi Y, Kabashima A, Yamamoto H, Shimabukuro R, Ojima Y, Yamamura S et al. A case of advanced esophageal cancer responding remarkably to chemotherapy of TS-1 and weekly CDDP combined with radiotherapy. Gan to kagaku ryoho. Cancer & chemotherapy. 2004 Jan 1;31(13):2159-2162.
Sakaguchi, Yoshihisa ; Kabashima, Akira ; Yamamoto, Hideki ; Shimabukuro, Rinshun ; Ojima, Yasutomo ; Yamamura, Shinji ; Nishizaki, Takashi ; Tashiro, Hideya ; Matsusaka, Toshimitsu. / A case of advanced esophageal cancer responding remarkably to chemotherapy of TS-1 and weekly CDDP combined with radiotherapy. In: Gan to kagaku ryoho. Cancer & chemotherapy. 2004 ; Vol. 31, No. 13. pp. 2159-2162.
@article{c37ad21e869e496d92189c0a1b23ecb6,
title = "A case of advanced esophageal cancer responding remarkably to chemotherapy of TS-1 and weekly CDDP combined with radiotherapy",
abstract = "A 66-year-old patient, who had advanced esophageal cancer with lymph node metastasis, was treated by neoadjuvant chemo-radiotherapy, followed by curative surgery. Chemotherapy of TS-1 (80 mg/m2) was administered orally for 21 days, and weekly intravenous administration of CDDP (20 mg/m2) was done 3 times. Radiotherapy at 2 Gy/day was combined 15 times (total 30 Gy). The tumor responded well to the treatment, and the size was remarkably reduced. Chemoradiotherapy using TS-1 and weekly CDDP revealed their efficacy for esophageal cancer.",
author = "Yoshihisa Sakaguchi and Akira Kabashima and Hideki Yamamoto and Rinshun Shimabukuro and Yasutomo Ojima and Shinji Yamamura and Takashi Nishizaki and Hideya Tashiro and Toshimitsu Matsusaka",
year = "2004",
month = "1",
day = "1",
language = "English",
volume = "31",
pages = "2159--2162",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "13",

}

TY - JOUR

T1 - A case of advanced esophageal cancer responding remarkably to chemotherapy of TS-1 and weekly CDDP combined with radiotherapy

AU - Sakaguchi, Yoshihisa

AU - Kabashima, Akira

AU - Yamamoto, Hideki

AU - Shimabukuro, Rinshun

AU - Ojima, Yasutomo

AU - Yamamura, Shinji

AU - Nishizaki, Takashi

AU - Tashiro, Hideya

AU - Matsusaka, Toshimitsu

PY - 2004/1/1

Y1 - 2004/1/1

N2 - A 66-year-old patient, who had advanced esophageal cancer with lymph node metastasis, was treated by neoadjuvant chemo-radiotherapy, followed by curative surgery. Chemotherapy of TS-1 (80 mg/m2) was administered orally for 21 days, and weekly intravenous administration of CDDP (20 mg/m2) was done 3 times. Radiotherapy at 2 Gy/day was combined 15 times (total 30 Gy). The tumor responded well to the treatment, and the size was remarkably reduced. Chemoradiotherapy using TS-1 and weekly CDDP revealed their efficacy for esophageal cancer.

AB - A 66-year-old patient, who had advanced esophageal cancer with lymph node metastasis, was treated by neoadjuvant chemo-radiotherapy, followed by curative surgery. Chemotherapy of TS-1 (80 mg/m2) was administered orally for 21 days, and weekly intravenous administration of CDDP (20 mg/m2) was done 3 times. Radiotherapy at 2 Gy/day was combined 15 times (total 30 Gy). The tumor responded well to the treatment, and the size was remarkably reduced. Chemoradiotherapy using TS-1 and weekly CDDP revealed their efficacy for esophageal cancer.

UR - http://www.scopus.com/inward/record.url?scp=13744256593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13744256593&partnerID=8YFLogxK

M3 - Article

C2 - 15628763

AN - SCOPUS:13744256593

VL - 31

SP - 2159

EP - 2162

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 13

ER -